Related Experiment Video
Updated: Aug 20, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
Nucleotide degradation products in cerebrospinal fluid (CSF) in inherited and acquired pathologies
L D Fairbanks1, J C Harris, J A Duley
1Purine Research Unit, Guy's Hospital, London, UK.
Abstract:
CSF purines were grossly elevated compared with controls only in adenylosuccinate lyase (ADSL) deficiency and TB meningitis. The former representing low permeability, the latter severe damage to the normal blood/brain barrier. By contrast, the similarity to controls, with no difference between Lesch-Nyhan disease (LND) or LND variants, would exclude hypoxia as a factor in the severe neurological deficits in LND. Similar findings in purine nucleoside phosphorylase (PNP) deficiency (although nucleosides replace the normal bases) likewise exclude hypoxia in the aetiology of the albeit milder neurological deficits.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Nuclear Export of mRNA
Biosynthesis of Nucleic Acids
Parkinson Disease ll: Pathophysiology
Cerebrospinal Fluid
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain.
